Szabó T - Search Results

1

Increased catabolic activity in adipose tissue of patients with chronic heart failure.

Szabó T, Postrach E, Mähler A, Kung T, Turhan G, von Haehling S, Anker SD, Boschmann M, Doehner W. Szabó T, et al. Eur J Heart Fail. 2013 Oct;15(10):1131-7. doi: 10.1093/eurjhf/hft067. Epub 2013 May 21. Eur J Heart Fail. 2013. PMID: 23696611 Free article.

2

Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.

Szabó T, Scherbakov N, Sandek A, Kung T, von Haehling S, Lainscak M, Jankowska EA, Rudovich N, Anker SD, Frystyk J, Flyvbjerg A, Pfeiffer AF, Doehner W. Szabó T, et al. Nutr Metab Cardiovasc Dis. 2014 Jan;24(1):50-6. doi: 10.1016/j.numecd.2013.04.015. Epub 2013 Jun 19. Nutr Metab Cardiovasc Dis. 2014. PMID: 23791298

3

Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure.

Szabo T, von Haehling S, Habedank D, Rauchhaus M, Lainscak M, Sandek A, Schefold J, Anker SD, Doehner W. Szabo T, et al. Int J Cardiol. 2011 Feb 17;147(1):47-51. doi: 10.1016/j.ijcard.2009.07.030. Epub 2009 Sep 5. Int J Cardiol. 2011. PMID: 19733925

4

Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.

Scherbakov N, Bauer M, Sandek A, Szabó T, Töpper A, Jankowska EA, Springer J, von Haehling S, Anker SD, Lainscak M, Engeli S, Düngen HD, Doehner W. Scherbakov N, et al. Among authors: szabo t. Eur J Heart Fail. 2015 Oct;17(10):1015-21. doi: 10.1002/ejhf.317. Epub 2015 Jul 21. Eur J Heart Fail. 2015. PMID: 26198713 Free article.

5

Overview of emerging pharmacotherapy in chronic heart failure.

Szabó T, Felger D, von Haehling S, Lainscak M, Anker SD, Doehner W. Szabó T, et al. Expert Opin Pharmacother. 2009 Sep;10(13):2055-74. doi: 10.1517/14656560903117291. Expert Opin Pharmacother. 2009. PMID: 19606938 Review.

6

Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour.

Ebner N, Földes G, Szabo T, Tacke M, Fülster S, Sandek A, Doehner W, Anker SD, von Haehling S. Ebner N, et al. Among authors: szabo t. Clin Res Cardiol. 2013 Feb;102(2):95-101. doi: 10.1007/s00392-012-0499-0. Epub 2012 Aug 10. Clin Res Cardiol. 2013. PMID: 22878732

7

Systolic heart failure.

Szabo T, Doehner W, Anker SD. Szabo T, et al. N Engl J Med. 2010 Apr 22;362(16):1545; author reply 1545-6. N Engl J Med. 2010. PMID: 20414982 No abstract available.

8

Cachexia in heart disease: highlights from the ESC 2010.

Kung T, Szabó T, Springer J, Doehner W, Anker SD, von Haehling S. Kung T, et al. Among authors: szabo t. J Cachexia Sarcopenia Muscle. 2011 Mar;2(1):63-69. doi: 10.1007/s13539-011-0020-z. Epub 2011 Feb 24. J Cachexia Sarcopenia Muscle. 2011. PMID: 21475672 Free PMC article.

9

Differentiating between body fat and lean mass--how should we measure obesity?

Szabó T, von Haehling S, Doehner W. Szabó T, et al. Nat Clin Pract Endocrinol Metab. 2008 Nov;4(11):E1; author reply E2. doi: 10.1038/ncpendmet0999. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18946485 No abstract available.

10

Weight change with beta-blocker use: a side effect put into perspective.

Szabó T, von Haehling S, Doehner W. Szabó T, et al. Am J Med. 2008 May;121(5):e15; author reply e17. doi: 10.1016/j.amjmed.2008.01.031. Am J Med. 2008. PMID: 18456014 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

545 results

Search Page